Industry committee  Basically, yes. That's going to be a government policy issue, though. So West Nile virus--where you would actually vaccinate a human probably--would be something that you could have. Saskatchewan is a very...I won't say susceptible population, but it's a population where the dise

Industry committee  Certainly. Again, our institution is about 33 years old. From a very early stage, VIDO recognized the importance of intellectual property and patenting. So I guess from a very early age, if you want to talk of business sustainable, competitive advantage, basically a patent does

Industry committee  When I spoke of advance market commitment, I was speaking more from a human health perspective. I do not know whether the government as a policy wants to do the same sort of thing for animal health vaccine. That's a very interesting vaccine, because it's a bacteria that causes

Industry committee  The Vaccine Infectious Disease Organization is part of the University of Saskatchewan, so we tend not to deal with that early-stage investment, where most of our discoveries or inventions are pre-licensed to some of the large pharma and biotechnology companies. So I'd have diffic

Industry committee  Unfortunately, I agree 100%. The majority of scientists have failed drastically in their ability to communicate their research to the general public. I was a scientist in my past life. VIDO has been somewhat of an exception in that, and we take several fronts to try to translat

Industry committee  I guess from VIDO's perspective we're in a somewhat enviable position of having interacted with companies for approximately 35 years. That's created a reputation for us with these companies. I mentioned we had 80 patents. Patents by themselves are nothing but a money sink. When y

Industry committee  We will buy 50 million doses of this vaccine over the next 10 years.

Industry committee  One of the principal ways we can address that is by creating a corporate culture that's friendly to the scientists. Alberta has started doing that with the Alberta Ingenuity Fund. VIDO has done it for about 30 years with our scientists, and we've been very successful in recruitin

Industry committee  Thank you, Mr. Chair. On behalf of the Vaccine and Infectious Disease Organization, I would like to thank the committee for the opportunity to present the history of our organization as well as its past successes, future challenges, and associated opportunities. The Vaccine and

Industry committee  My apologies. I'm going to go overtime now for sure.

Industry committee  Historically we have focused on veterinary diseases. However, the convergence of human and animal health has expanded our mission to the health of all species. This expertise was recently recognized by funding from the Bill and Melinda Gates Foundation for a single-shot vaccine f